A fetal sheep liver extract containing immunostimulatory substances including LPS acts as leukocyte activator in cells of LPS responder and non responder mice.

Détails

ID Serval
serval:BIB_37777
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
A fetal sheep liver extract containing immunostimulatory substances including LPS acts as leukocyte activator in cells of LPS responder and non responder mice.
Périodique
International Immunopharmacology
Auteur⸱e⸱s
Müller S., Hoffmann P., Esche U.V., Mach J.P., Gorczynski R.M., Waelli T., Alexander C., Zähringer U., Rietschel E.T., Bessler W.G., Westphal O.
ISSN
1567-5769 (Print)
ISSN-L
1567-5769
Statut éditorial
Publié
Date de publication
2005
Peer-reviewed
Oui
Volume
5
Numéro
13-14
Pages
1809-1819
Langue
anglais
Résumé
Purified fractions from a fetal sheep liver extract (FSLE) were investigated, in a murine model, for induction of leukocyte stimulating activities. The fractions FSLE-1 and FSLE-2 induced splenocyte proliferation in vitro in C57Bl/10ScSn (LPS responder) mice comparable to LPS, and in C57Bl/10ScCr (LPS non responder) mice. They also stimulated the release of nitrogen radicals in bone marrow-derived macrophages (BMDM) from several mouse inbred strains including both C57Bl/10ScSn and C57Bl/10ScCr mice. Stimulation of NO production could be blocked by L-NMMA, an inhibitor of iNOS, and enhanced by the simultaneous addition of IFN-gamma. Moreover, stimulation of macrophages by FSLE-1 and FSLE-2 induced a cytostatic effect of the activated macrophages for Abelson 8-1 tumor cells. The stimulatory activity of the purified fractions is partially due to trace amounts of LPS derived from the fetal liver extract which was enriched during purification. Our results may help to explain the beneficial effect of the extract in patients which has been observed clinically.
Mots-clé
Animals, Cell Line, Tumor/drug effects, Cell Line, Tumor/metabolism, Cell Proliferation/drug effects, Coculture Techniques, Dose-Response Relationship, Drug, Immunologic Factors/isolation & purification, Immunologic Factors/pharmacology, Interferon-gamma/pharmacology, Leukocytes/drug effects, Lipopolysaccharides/isolation & purification, Lipopolysaccharides/pharmacology, Liver/chemistry, Liver/embryology, Macrophages/drug effects, Macrophages/metabolism, Mice, Mice, Inbred C57BL, Nitric Oxide/metabolism, Nitric Oxide Synthase Type II/antagonists & inhibitors, Sheep/embryology, Spleen/cytology, Spleen/drug effects, omega-N-Methylarginine/pharmacology
Pubmed
Web of science
Création de la notice
19/11/2007 13:36
Dernière modification de la notice
20/08/2019 14:25
Données d'usage